PT2573105E - Péptidos derivados de p16ink4a para profilaxia e terapia de tumores associados a hpv e outros tumores expressando p16ink4a - Google Patents

Péptidos derivados de p16ink4a para profilaxia e terapia de tumores associados a hpv e outros tumores expressando p16ink4a Download PDF

Info

Publication number
PT2573105E
PT2573105E PT110076858T PT11007685T PT2573105E PT 2573105 E PT2573105 E PT 2573105E PT 110076858 T PT110076858 T PT 110076858T PT 11007685 T PT11007685 T PT 11007685T PT 2573105 E PT2573105 E PT 2573105E
Authority
PT
Portugal
Prior art keywords
p16ink4a
tumors
hpv
prophylaxis
therapy
Prior art date
Application number
PT110076858T
Other languages
English (en)
Inventor
Matthias Kloor
Miriam Reuschenbach
Magnus Knebel-Doeberitz
Original Assignee
Ruprecht Karls Universität Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ruprecht Karls Universität Heidelberg filed Critical Ruprecht Karls Universität Heidelberg
Publication of PT2573105E publication Critical patent/PT2573105E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001148—Regulators of development
    • A61K39/001149—Cell cycle regulated proteins, e.g. cyclin, CDC, CDK or INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PT110076858T 2011-09-21 2011-09-21 Péptidos derivados de p16ink4a para profilaxia e terapia de tumores associados a hpv e outros tumores expressando p16ink4a PT2573105E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11007685.8A EP2573105B1 (en) 2011-09-21 2011-09-21 p16INK4a derived peptides for prophylaxis and therapy of HPV-associated tumors and other p16INK4a expressing tumors

Publications (1)

Publication Number Publication Date
PT2573105E true PT2573105E (pt) 2016-02-25

Family

ID=44719081

Family Applications (1)

Application Number Title Priority Date Filing Date
PT110076858T PT2573105E (pt) 2011-09-21 2011-09-21 Péptidos derivados de p16ink4a para profilaxia e terapia de tumores associados a hpv e outros tumores expressando p16ink4a

Country Status (5)

Country Link
EP (1) EP2573105B1 (pt)
CY (1) CY1117135T1 (pt)
DK (1) DK2573105T3 (pt)
ES (1) ES2560108T3 (pt)
PT (1) PT2573105E (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104837497B (zh) * 2012-12-13 2018-06-29 海德堡吕布莱希特-卡尔斯大学 用于预防和治疗HPV-相关的肿瘤和其它表达p16的肿瘤的p16INK4a衍生肽
CN114163510A (zh) * 2021-03-24 2022-03-11 深圳市新靶向生物科技有限公司 一种与肝癌驱动基因突变相关的抗原肽组合及其应用

Also Published As

Publication number Publication date
ES2560108T3 (es) 2016-02-17
CY1117135T1 (el) 2017-04-05
EP2573105B1 (en) 2015-10-28
DK2573105T3 (en) 2015-12-21
EP2573105A1 (en) 2013-03-27

Similar Documents

Publication Publication Date Title
HK1252157A1 (zh) 重組病毒產品和抑制dux4表達的方法
HK1199892A1 (en) Modified mini-hepcidin peptides and methods of using thereof
HK1201658A1 (en) Secure distribution of content
EP2536827A4 (en) PROCESS FOR PRODUCING THERAPEUTIC PRODUCTS WITH VITALIZED PLAZENTA DISPERSION
IL279676A (en) Recombinant proteins and therapeutic uses
EP2884894A4 (en) METHOD FOR DETERMINING THE SIZE OF BODY PARTS AS PART OF COMPRESSION THERAPY PROCEDURES
SG184289A1 (en) Novel peptides and methods for their preparation and use
EP2553102A4 (en) EXPRESSION OF RECOMBINANT TOXIN PROTEINS IN HIGH QUANTITY
ZA201302939B (en) Expression vector for high level expression of recombinant proteins
HK1178465A1 (en) Composition for improving condition of skin
EP2605786A4 (en) THERAPEUTIC PEPTIDES
HK1203161A1 (en) Peptides and methods of using same
GB201016832D0 (en) Garment technology for application of therapeutic pressure
EP2852403A4 (en) METHOD FOR MODIFYING TISSUE
EP2909238A4 (en) IMPROVED IMMUNOTHERAPY AGAINST HUMAN HERPESVIRUS
ZA201208389B (en) Treatment of proliferative diseases
EP2699673A4 (en) RECOMBINANT VIRUS PRODUCTS AND METHODS FOR EXPRESSION INHIBITION OF MYOTILINE
EP2911692A4 (en) USE OF ENDOCYTOSE INHIBITORS AND ANTIBODIES FOR ANTICANCER THERAPY
EP2522360A4 (en) VACCINE FOR TAUTOPATHY TREATMENT
PT2573105E (pt) Péptidos derivados de p16ink4a para profilaxia e terapia de tumores associados a hpv e outros tumores expressando p16ink4a
EP3560952C0 (en) VARIANT OF BPIFB4 PROTEIN
LT2460509T (lt) Kompozicija, skirta karpų gydymui
PL2513060T3 (pl) Krystaliczna postać α karbabenzopirydu
PT2555790T (pt) USO TERAPÊUTICO DA PROTEÍNA DE ß MICROGLOBULINA
ZA201400488B (en) Compounds for the treatment of cancers associated with human papillomavirus